- Home
- MRNA vs PAC Comparison
MRNA vs PAC Comparison
Compare MRNA & PAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- PAC
- Stock Information
- Founded
- MRNA 2010
- PAC 1998
- Country
- MRNA United States
- PAC Mexico
- Employees
- MRNA N/A
- PAC N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- PAC Aerospace
- Sector
- MRNA Health Care
- PAC Consumer Discretionary
- Exchange
- MRNA Nasdaq
- PAC Nasdaq
- Market Cap
- MRNA 10.6B
- PAC 10.4B
- IPO Year
- MRNA 2018
- PAC 2006
- Fundamental
- Price
- MRNA $26.56
- PAC $230.35
- Analyst Decision
- MRNA Hold
- PAC Buy
- Analyst Count
- MRNA 19
- PAC 6
- Target Price
- MRNA $48.13
- PAC $207.50
- AVG Volume (30 Days)
- MRNA 14.2M
- PAC 82.2K
- Earning Date
- MRNA 05-01-2025
- PAC 07-22-2025
- Dividend Yield
- MRNA N/A
- PAC 3.35%
- EPS Growth
- MRNA N/A
- PAC N/A
- EPS
- MRNA N/A
- PAC 0.86
- Revenue
- MRNA $3,177,000,000.00
- PAC $1,435,598,195.00
- Revenue This Year
- MRNA N/A
- PAC $57.91
- Revenue Next Year
- MRNA $8.98
- PAC $8.28
- P/E Ratio
- MRNA N/A
- PAC $26.60
- Revenue Growth
- MRNA N/A
- PAC 14.67
- 52 Week Low
- MRNA $23.15
- PAC $146.62
- 52 Week High
- MRNA $158.82
- PAC $234.21
- Technical
- Relative Strength Index (RSI)
- MRNA 50.60
- PAC 62.01
- Support Level
- MRNA $25.22
- PAC $223.43
- Resistance Level
- MRNA $27.15
- PAC $231.21
- Average True Range (ATR)
- MRNA 1.61
- PAC 5.62
- MACD
- MRNA 0.26
- PAC -0.41
- Stochastic Oscillator
- MRNA 47.66
- PAC 70.12
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About PAC Grupo Aeroportuario Del Pacifico S.A. B. de C.V. Grupo Aeroportuario Del Pacifico S.A. de C.V. (each representing 10 Series B shares)
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the construction, development, and operation of airports in Mexico. The company's segment includes Guadalajara; Tijuana; Puerto Vallarta; San Jose del Cabo; Montego Bay; Hermosillo; Guanajuato and Other Airports. It generates maximum revenue from the Guadalajara segment.